February 10, 2017 10:12 AM ESTUpdated 10:52 AM
News Briefing

Tra­con shares slammed by PhII bust in brain can­cer study; Vis­ter­ra yanks its IPO in back-to-back duds

Shehla Shakoor

Managing Director

• Shares of San Diego-based Tra­con $TCON got slammed this morn­ing af­ter in­ves­ti­ga­tors said that the Phase II NCI study of TRC105 in re­cur­rent glioblas­toma …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times